Lv610
2338 积分 2022-11-12 加入
USP5 inhibition enables potential therapy for t(8;21) AML through ubiquitin-mediated AML1-ETO degradation in patient-derived xenografts
2天前
已完结
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate
3天前
已完结
USP5 inhibition enables potential therapy for t(8;21) AML through ubiquitin-mediated AML1-ETO degradation in patient-derived xenografts
3天前
已完结
Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma
20天前
已完结
Pretreatment Tumor NECTIN4 RNA Expression Is Associated with First-line Enfortumab Vedotin Plus Pembrolizumab Efficacy in Metastatic Urothelial Cancer
20天前
已完结
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes
29天前
已完结
Enfortumab vedotin induces immunogenic cell death and shows enhanced preclinical antitumor activity when combined with a PD-1 inhibitor
1个月前
已完结
CircSTK39 suppresses the proliferation and invasion in Bladder Cancer via regulating miR-135a-5p/NR3C2-mediated Epithelial-Mesenchymal Transition signaling pathway
1个月前
已关闭
PRRSV disrupted nasal mucosal homeostasis by initiating Notch signaling to induce goblet cell differentiation
1个月前
已完结
CRISPR screens identify targets to rescue age-related T cell dysfunction in cancer
1个月前
已完结
皖公网安备34019202002308
